Datwin, Ariannah Mae L.
HRN: 22-97-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2025
CEFUROXIME 750MG (VIAL)
05/23/2025
05/30/2025
IV
440mg
Q8
Acute Bacterial Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes